# OnCo record nct00045149 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00045149/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00045149", "NCT00045149" ;
  schema:name "CD8+ T-cell clones against cancer-testis antigens in metastatic melanoma (Fred Hutchinson phase 1)"@en ;
  schema:description "A Seattle safety trial of killer T cells grown to recognise cancer-testis proteins, which melanomas can carry but most normal adult tissues do not. It ran from 2002 to 2005."@en ;
  schema:url <https://onco.cc/trials/nct00045149/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00045149> ;
  onco:status "completed" ;
  onco:phase "1" ;
  schema:startDate "2002-10" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/aldesleukin/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/>, <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/> ;
  onco:people <https://onco.cc/people/cassian-yee/> .